Search for: "Alexion Pharmaceuticals"
Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
HSMN NewsFeed,
16 Apr 2010:
Biopharmaceuticals, Regulatory
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH]
|
Alexion Appoints William R. Keller to its Board of Directors
HSMN NewsFeed,
1 Dec 2009:
Biopharmaceuticals, Personnel
[Alexion Pharmaceuticals]
|
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
HSMN NewsFeed,
1 Apr 2009:
Biopharmaceuticals, Regulatory
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH, AEGIS Study]
|
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Mergers & Acquisitions
[CytRx, Innovive Pharmaceuticals]
|
Vertos Medical Inc. Completes Series C Financing
HSMN NewsFeed,
17 Jul 2008:
Devices, Neurosurgery, Orthopaedic, Venture Capital
[Vertos Medical]
|
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
HSMN NewsFeed,
9 Jun 2008:
Biopharmaceuticals, Mergers & Acquisitions
[CytRx, Innovive Pharmaceuticals]
|
Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
HSMN NewsFeed,
6 May 2008:
Biopharmaceuticals, Personnel
[Rib-X Pharmaceuticals]
|
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
HSMN NewsFeed,
24 Apr 2008:
Biopharmaceuticals, Personnel
[Transdel Pharmaceuticals]
|
Anaphore, Inc Receives $8M Financing
HSMN NewsFeed,
15 Apr 2008:
Biopharmaceuticals, Venture Capital
[Anaphore]
|
Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
HSMN NewsFeed,
20 Mar 2008:
[Alexion Pharmaceuticals, AEGIS study, Soliris, eculizumab, PNH]
|
Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
HSMN NewsFeed,
14 Feb 2008:
Biopharmaceuticals
[Alexion Pharmaceuticals, Soliris, eculizumab, complement inhibitor, PNH]
|
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
HSMN NewsFeed,
11 Dec 2007:
Biopharmaceuticals
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH]
|
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
HSMN NewsFeed,
10 Dec 2007:
Biopharmaceuticals
[Alexion Pharmaceuticals, paroxysmal nocturnal hemoglobinuria, Soliris,eculizumab]
|
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
HSMN NewsFeed,
4 Dec 2007:
Biopharmaceuticals
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH , SHEPHERD study]
|
Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
HSMN NewsFeed,
3 Oct 2007:
Biopharmaceuticals, Personnel
[Prism Pharmaceuticals]
|
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
HSMN NewsFeed,
20 Aug 2007:
Biopharmaceuticals
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH]
|
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
HSMN NewsFeed,
22 Jun 2007:
Biopharmaceuticals, Regulatory
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH]
|
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
HSMN NewsFeed,
11 Jun 2007:
Biopharmaceuticals
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH]
|
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH, aplastic anemia, MDS]
|
CHMP Adopts Positive Opinion for Alexion's Soliris(TM) in Europe
HSMN NewsFeed,
27 Apr 2007:
Biopharmaceuticals, Regulatory
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH]
|
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
HSMN NewsFeed,
9 Apr 2007:
Biopharmaceuticals, Personnel
[PDL BioPharma]
|
Rincon Pharmaceuticals Appoints Dr. Peter B. Heifetz as Chief Scientific Officer, Drs. Jacqueline J. Johnson and Alan J. Lewis to Board of Directors, and Drs. Katherine S. Bowdish and Mich B. Hein to Scientific Advisory Board
HSMN NewsFeed,
28 Mar 2007:
Biopharmaceuticals, Personnel
[Rincon Pharmaceuticals]
|
Update: FDA Approves Alexion's Soliris(TM) for All Patients With PNH
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, FDA
[Alexion Pharmaceuticals, Soliris, eculizumab, PNH]
|
FDA Approves Alexion's Soliris(TM) for All Patients With PNH
HSMN NewsFeed,
16 Mar 2007:
Biopharmaceuticals, FDA
[Alexion Pharmaceutical, Soliris, eculizumab, paroxysmal nocturnal hemoglobinuria]
|
Eculizumab is Well Tolerated and Demonstrates Significant Improvement During 52 Weeks of Treatment in Open-Label Phase III SHEPHERD Study in PNH Patients
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals
[Alexion Pharmaceuticals, Eculizumab, paroxysmal nocturnal hemoglobinuria]
|
FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria
HSMN NewsFeed,
14 Nov 2006:
Biopharmaceuticals, FDA
[Alexion Pharmaceuticals, Soliris, eculizumab, Nocturnal Hemoglobinuria]
|
Alexion Submits Market Authorization Application for Soliris(TM) (eculizumab) in the Treatment of Paroxysmal Nocturnal Hemoglobinuria to the European Medicines Agency
HSMN NewsFeed,
26 Sep 2006:
Biopharmaceuticals, Regulatory
[Alexion Pharmaceuticals, Soliris, eculizumab, hemoglobinuria]
|
Alexion Pharmaceuticals Purchases Biopharmaceutical Manufacturing Site in Rhode Island
HSMN NewsFeed,
13 Jul 2006:
Biopharmaceuticals
[Alexion Pharmaceuticals, Soliris]
|
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
HSMN NewsFeed,
6 Jul 2006:
Biopharmaceuticals, Personnel
[Alexion Pharmaceuticals]
|
Alexion Announces the EXPLORE Clinical Diagnostic Study for Paroxysmal Nocturnal Hemoglobinuria (PNH)
HSMN NewsFeed,
16 Jun 2006:
Biopharmaceuticals
[Alexion Pharmaceuticals, Paroxysmal Nocturnal Hemoglobinuria, EXPLORE study]
|
Alexion Pharmaceuticals Reports Positive Interim Safety and Efficacy Results for Soliris(TM) (eculizumab) From the Open-Label Phase III SHEPHERD Safety Trial in Paroxysmal Nocturnal Hemoglobinuria Patients
HSMN NewsFeed,
12 Jun 2006:
Biopharmaceuticals
[Alexion Pharmaceuticals, Soliris, eculizumab]
|
Insulet Corporation Names Carsten Boess Chief Financial Officer
HSMN NewsFeed,
8 Jun 2006:
Devices, Drug Delivery, Personnel
[Insulet Corp, OmniPod]
|
Alexion Updates Previously Announced Phase III Results for PRIMO-CABG2 Study
HSMN NewsFeed,
13 Mar 2006:
Biopharmaceuticals, Cardiology
[Alexion Pharmaceuticals, Procter and Gamble, PRIMO-CABG2, pexelizumab]
|
Alexion Pharmaceuticals Provides Update on APEX-AMI Trial
HSMN NewsFeed,
3 Feb 2006:
Biopharmaceuticals
[Alexion Pharmaceuticals, Procter & Gamble, APEX-AMI trial, pexelizumab]
|
Alexion Pharmaceuticals Reports Positive Phase III Results for Eculizumab From Pivotal TRIUMPH Efficacy Trial in Paroxysmal Nocturnal Hemoglobinuria Patients
HSMN NewsFeed,
26 Jan 2006:
Biopharmaceuticals
[Alexion Pharmaceuticals, eculizumab, Soliris, PNH , TRIUMPH trial]
|
CancerVax and Micromet Announce Merger Agreement
HSMN NewsFeed,
9 Jan 2006:
Biopharmaceuticals, Mergers & Acquisitions
[CancerVax, Micromet AG]
|
Sapphire Therapeutics, Inc. Builds Drug Development Team Through New Hires and Promotion
HSMN NewsFeed,
6 Jan 2006:
Biopharmaceuticals, Personnel
[Sapphire Therapeutics]
|
Alexion Completes Patient Treatment in Its Phase III Pivotal TRIUMPH Efficacy Trial of Eculizumab in PNH Patients
HSMN NewsFeed,
4 Jan 2006:
Biopharmaceuticals
[Alexion Pharmaceuticals, TRIUMPH trial, PNH , eculizumab]
|
|
|
Public
Feeds 
Full text >>
